n-formylmethionylvaline has been researched along with Dermatitis, Atopic in 1 studies
*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapp, A; Schöpf, E | 1 |
1 other study(ies) available for n-formylmethionylvaline and Dermatitis, Atopic
| Article | Year |
|---|---|
Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis--measurement of lucigenin-dependent chemiluminescence.
Topics: Acridines; Adult; Complement C5; Complement C5a; Dermatitis, Atopic; Dipeptides; Female; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Oxygen; Psoriasis; Stimulation, Chemical; Tetradecanoylphorbol Acetate; Zymosan | 1986 |